tirzepatide 2023 Lilly's Zepbound (aka tirzepatide) Lands FDA Approval for Weight Loss Now offering Tirzepatide (Generic Mounjaro)

Individual results will vary

Stacking with other peptides or medications Combining dual agonists with other weight loss medications is generally not recommended

As well, "none of the participants in any of the studies analyzed by the team experienced pulmonary aspiration" linked to delayed stomach emptying, the team explained in a Brigham news release

While Mounjaro shows promising weight loss outcomes in clinical trials, success depends on maintaining healthy lifestyle habits throughout the transition

Eleftheriadou A, Riley D, Zhao SS et al (2024) Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database